In order to clarify the relationship between coronary artery disease (including myocardial infarction) and image contrast in gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA)-enhanced MRI it was decided to model the myocardial tissue distribution and clearance of Gd-DTPA using the modified Kety equation. Using a canine model, myocardial tissue Gd-DTPA concentrations ([Gd-DTPA]m) were measured 1 or 5 min after a bolus injection of Gd-DTPA or immediately after the end of a constant infusion of Gd-DTPA in a total of 35 dogs. It was found that within 5 min of a bolus injection [Gd-DTPA]m is determined primarily by myocardial blood flow (MBF) and after about 10 min primarily by myocardial extracellular volumes (MECV). This study suggests that repeat, rapid (every 2-4 s) measurements of myocardial T1 relaxation rates following the bolus injection of Gd-DTPA are required to calculate MBF (i.e., myocardial tissue perfusion) and MECV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mrm.1910230205 | DOI Listing |
Cochrane Database Syst Rev
March 2025
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Background: Large hemispheric infarction (LHI), caused by occlusion of the internal carotid or middle cerebral artery, is the most malignant type of supratentorial ischemic stroke. Due to severe intracranial edema, mortality fluctuates between 53% and 78%, even after the most effective medical treatment. Decompressive craniectomy can reduce mortality by approximately 17% to 36%, but the neurological outcomes are not satisfactory, and there are contraindications to surgery.
View Article and Find Full Text PDFFront Neurol
February 2025
Department of Neurosurgery, Cerebrovascular Diseases Center, Renji Hospital, Shanghai, China.
Endovascular mechanical thrombectomy (EMT) is an effective treatment for acute ischemic stroke and identifying the precise thrombus size remains key to a successful EMT. However, no imaging modality has been able to provide this information simultaneously and efficiently in an emergency setting. The present study introduces a novel technique named dual-channel bolus contrast injection (Dc-BCI) for determining thrombus size and location during EMT.
View Article and Find Full Text PDFBr J Clin Pharmacol
March 2025
Crinetics Pharmaceuticals, San Diego, CA, USA.
Aims: Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Methods: In Part A of the two-part, phase 1 study, a single dose (oral solution) of 20 mg paltusotine containing approximately 3.
BMC Med Imaging
March 2025
Department of Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
Objective: To evaluate the effectiveness of the variable rate bolus tracking technique combined with third-generation dual-source CT dual-energy scanning in enhancing the quality of head and neck vascular CT angiography (CTA).
Methods: We conducted a retrospective analysis of 202 patients who underwent head and neck vascular CTA using a third-generation dual-source CT with dual-energy scanning. Patients were divided based on the contrast injection method into two groups: the variable-rate bolus tracking group (Group A, n = 100) and the fixed flow rate group (Group B, n = 102).
Anal Methods
March 2025
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
Propofol, a fast-acting anesthetic, requires precise titration to minimize adverse effects. While plasma-based monitoring is slow, exhaled propofol offers a real-time, non-invasive alternative, though its clinical application remains limited. This study evaluates ultraviolet time-of-flight mass spectrometry (UV-TOF MS) for real-time monitoring, presenting its calibration and validation in Beagle dogs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!